These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19390864)

  • 1. Population programs for the detection of couples at risk for severe monogenic genetic diseases.
    Zlotogora J
    Hum Genet; 2009 Aug; 126(2):247-53. PubMed ID: 19390864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty-year outcome analysis of genetic screening programs for Tay-Sachs and beta-thalassemia disease carriers in high schools.
    Mitchell JJ; Capua A; Clow C; Scriver CR
    Am J Hum Genet; 1996 Oct; 59(4):793-8. PubMed ID: 8808593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for genetic disorders among Jews: how should the Tay-Sachs screening program be continued?
    Zlotogora J; Leventhal A
    Isr Med Assoc J; 2000 Sep; 2(9):665-7. PubMed ID: 11062764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY.
    Kronn D; Jansen V; Ostrer H
    Arch Intern Med; 1998 Apr; 158(7):777-81. PubMed ID: 9554684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the potential success of cystic fibrosis carrier screening: lessons learned from Tay-Sachs disease and beta-thalassemia.
    Laberge AM; Watts C; Porter K; Burke W
    Public Health Genomics; 2010; 13(5):310-9. PubMed ID: 19864874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal genetic carrier testing using triple disease screening.
    Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
    JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for thalassemia: a model of success.
    Cao A; Rosatelli MC; Monni G; Galanello R
    Obstet Gynecol Clin North Am; 2002 Jun; 29(2):305-28, vi-vii. PubMed ID: 12108831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population screening for reproductive risk for single gene disorders in Australia: now and the future.
    Delatycki MB
    Twin Res Hum Genet; 2008 Aug; 11(4):422-30. PubMed ID: 18637742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic screening for reproductive purposes at school: is it a good strategy?
    Frumkin A; Zlotogora J
    Am J Med Genet A; 2008 Jan; 146A(2):264-9. PubMed ID: 18080324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for carriers of Tay-Sachs disease in the ultraorthodox Ashkenazi Jewish community in Israel.
    Broide E; Zeigler M; Eckstein J; Bach G
    Am J Med Genet; 1993 Aug; 47(2):213-5. PubMed ID: 8213907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tay-Sachs disease screening and counseling families at risk for metabolic disease.
    Sutton VR
    Obstet Gynecol Clin North Am; 2002 Jun; 29(2):287-96. PubMed ID: 12108829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premarital screening for beta-thalassaemia in Southern Iran: options for improving the programme.
    Karimi M; Jamalian N; Yarmohammadi H; Askarnejad A; Afrasiabi A; Hashemi A
    J Med Screen; 2007; 14(2):62-6. PubMed ID: 17626703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carrier screening and genetic counselling in beta-thalassemia.
    Cao A
    Int J Hematol; 2002 Aug; 76 Suppl 2():105-13. PubMed ID: 12430909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International perspectives on the implementation of reproductive carrier screening.
    Delatycki MB; Alkuraya F; Archibald A; Castellani C; Cornel M; Grody WW; Henneman L; Ioannides AS; Kirk E; Laing N; Lucassen A; Massie J; Schuurmans J; Thong MK; van Langen I; Zlotogora J
    Prenat Diagn; 2020 Feb; 40(3):301-310. PubMed ID: 31774570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterozygote carrier testing in high schools abroad: what are the lessons for the U.S.?
    Ross LF
    J Law Med Ethics; 2006; 34(4):753-64. PubMed ID: 17199818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community genetics and dignity in diversity in the Quebec Network of Genetic Medicine.
    Scriver CR
    Community Genet; 2006; 9(3):142-52. PubMed ID: 16741343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and β-thalassemia in Saudi Arabia.
    Memish ZA; Saeedi MY
    Ann Saudi Med; 2011; 31(3):229-35. PubMed ID: 21623050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The frequency of Tay-Sachs disease causing mutations in the Brazilian Jewish population justifies a carrier screening program.
    Rozenberg R; Pereira Lda V
    Sao Paulo Med J; 2001 Jul; 119(4):146-9. PubMed ID: 11500789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tay-Sachs disease--carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. The International TSD Data Collection Network.
    Kaback M; Lim-Steele J; Dabholkar D; Brown D; Levy N; Zeiger K
    JAMA; 1993 Nov; 270(19):2307-15. PubMed ID: 8230592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tay Sachs disease in Australia: reduced disease incidence despite stable carrier frequency in Australian Jews.
    Lew RM; Proos AL; Burnett L; Delatycki M; Bankier A; Fietz MJ
    Med J Aust; 2012 Dec; 197(11):652-4. PubMed ID: 23230938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.